KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Equity Income: 2010-2024

Historic Equity Income for Tenet Healthcare (THC) over the last 15 years, with FY2024 value amounting to $260.0 million.

  • Tenet Healthcare's Equity Income rose 322.58% to $64.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.0 million, marking a year-over-year decrease of 41.15%. This contributed to the annual value of $260.0 million for FY2024, which is 1403.51% up from last year.
  • Tenet Healthcare's Equity Income amounted to $260.0 million in FY2024, which was up 1403.51% from $228.0 million recorded in FY2023.
  • Tenet Healthcare's Equity Income's 5-year high stood at $260.0 million during FY2024, with a 5-year trough of $169.0 million in FY2020.
  • Moreover, its 5-year median value for Equity Income was $218.0 million (2021), whereas its average is $218.2 million.
  • In the last 5 years, Tenet Healthcare's Equity Income crashed by 342.86% in 2020 and then surged by 2899.41% in 2021.
  • Annual analysis of 5 years shows Tenet Healthcare's Equity Income stood at $169.0 million in 2020, then rose by 28.99% to $218.0 million in 2021, then fell by 0.92% to $216.0 million in 2022, then rose by 5.56% to $228.0 million in 2023, then increased by 14.04% to $260.0 million in 2024.
  • Its Equity Income stands at $260.0 million for FY2024, versus $228.0 million for FY2023 and $216.0 million for FY2022.